Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Temporal Trends and Determinants of Sodium-Glucose Cotransporter 2 Inhibitor Use in Patients Enrolled in a Nationwide Heart Failure Remote Monitoring Program

NCT07022379 is registered in ClinicalTrials.gov with Satelia as lead sponsor.

NCT NCT07022379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07022379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Temporal Trends and Determinants of Sodium-Glucose Cotransporter 2 Inhibitor Use in Patients Enrolled in a Nationwide Heart Failure Remote Monitoring Program
Lead sponsor
Satelia
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
December 31, 2024
Enrollment
13,660 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, heart failure with mildly reduced ejection fraction (hfmref), heart failure with preserved ejection fraction (hfpef), heart failure with reduced ejection fraction